Christine O’Day
-
- DNA and Nucleic Acid Chemistry 4
- RNA modifications and cancer 3
- DNA Repair Mechanisms 2
- Protein Degradation and Inhibitors 2
- Organic Chemistry top 10%
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Bladder and Urothelial Cancer Treatments 2
-
- Multiple Myeloma Research and Treatments 2
-
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- John‐Stephen TaylorNeil S. CutshallJohn AbelsonGloria Dalbadie‐McFarlandPeter BurgersKarl M. EbertTimothy EdmundsCatherine Bartlett
- Journals
- Journal of the American Chemical Society (2 papers)Nucleic Acids Research (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- United StatesJapan
In The Last Decade
Christine O’Day
19 papers receiving 700 citations
Peers
Comparison fields: 5 of 70
- Molecular Biology 526
- Organic Chemistry 158
- Toxicology 16
- Biochemistry 31
- Genetics 81
Countries citing papers authored by Christine O’Day
This map shows the geographic impact of Christine O’Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine O’Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine O’Day more than expected).
Fields of papers citing papers by Christine O’Day
This network shows the impact of papers produced by Christine O’Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine O’Day. The network helps show where Christine O’Day may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christine O’Day, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 10 | |
| 2 | 2022 | 2 | |
| 3 | 2021 | 2 | |
| 4 | 2015 | 8 | |
| 5 | 2011 | 2 | |
| 6 | 2010 | 1 | |
| 7 | 2010 | 1 | |
| 8 | Assessing cancer therapeutic agents across fifteen human tumor cell line panel | 2008 | 1 |
| 9 | 2007 | 7 | |
| 10 | 2005 | 172 | |
| 11 | 2000 | 46 | |
| 12 | 1996 | 66 | |
| 13 | 1996 | 37 | |
| 14 | 1996 | 97 | |
| 15 | 1992 | 67 | |
| 16 | 1991 | 72 | |
| 17 | 1990 | 61 | |
| 18 | 1989 | 4 | |
| 19 | 1987 | 64 |
About Christine O’Day
Christine O’Day is a scholar working on Hematology, Molecular Biology and Biophysics, having authored 19 papers that have together received 720 indexed citations. Recurring topics across this work include DNA and Nucleic Acid Chemistry (4 papers), RNA modifications and cancer (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), DNA Repair Mechanisms (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Multiple Myeloma Research and Treatments (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Molecular Biology (526 citations), Organic Chemistry (158 citations) and Toxicology (16 citations). Christine O’Day has collaborated with scholars based in United States and Japan. Frequent co-authors include John‐Stephen Taylor, Neil S. Cutshall, John Abelson, Gloria Dalbadie‐McFarland, Peter Burgers, Karl M. Ebert, Timothy Edmunds, Catherine Bartlett, John M. McPherson and Katherine Gordon. Their work appears in journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.